quinoxalines has been researched along with Huntington Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, P; Fu, Y; Gu, H; Guo, S; He, B; Hu, Y; Li, H; Li, Z; Lu, B; Luo, S; Pan, Y; Song, H; Sun, X; Wang, C; Wen, X; Xie, X; Zhao, Q; Zhou, Z | 1 |
| Gunn, RN; Haider, S; Kapur, S; Muhlert, N; Natesan, S; Niccolini, F; Piccini, P; Politis, M; Rabiner, EA; Reis Marques, T; Searle, GE; Tabrizi, SJ; Tziortzi, AC | 1 |
| Coello, C; Gunn, RN; Haider, S; Kapur, S; Marques, TR; Natesan, S; Niccolini, F; Pagano, G; Politis, M; Rabiner, EA; Tabrizi, SJ; Wilson, H | 1 |
| Brown, BL; Dallérac, G; Desvignes, N; Doyère, V; El Massioui, N; Faure, A; Höhn, S; Le Blanc, P; Nguyen, HP; Riess, O; Urbach, YK; von Hörsten, S | 1 |
| Hassam, R; Jones, S; Kung, VW; Morton, AJ | 1 |
| Labruyere, J; Olney, JW; Price, MT; Stewart, GR; Wang, GJ; Zorumski, CF | 1 |
6 other study(ies) available for quinoxalines and Huntington Disease
| Article | Year |
|---|---|
Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.
Topics: Age Factors; Animals; Benzamides; Corpus Striatum; Cyclic AMP; Disease Models, Animal; Drosophila; Drosophila Proteins; Exploratory Behavior; Gait; HEK293 Cells; Humans; Huntingtin Protein; Huntington Disease; Induced Pluripotent Stem Cells; Mice; Mice, Transgenic; Mutation; Neurons; Phenotype; Quinoxalines; Receptors, G-Protein-Coupled; Thiophenes; Walking | 2018 |
Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Topics: Adolescent; Adult; Brain Mapping; Female; Gene Expression Regulation, Enzymologic; Heterocyclic Compounds, 2-Ring; Humans; Huntingtin Protein; Huntington Disease; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Phosphoric Diester Hydrolases; Positron-Emission Tomography; Quinoxalines; Severity of Illness Index; Signal Transduction; Terminal Repeat Sequences; Young Adult | 2015 |
Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
Topics: Adult; Analysis of Variance; Brain; Carbon Radioisotopes; Female; Heterocyclic Compounds, 2-Ring; Humans; Huntington Disease; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Phosphoric Diester Hydrolases; Positron-Emission Tomography; Quinoxalines | 2016 |
Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease.
Topics: Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Animals, Genetically Modified; Behavior, Animal; Corpus Striatum; Discrimination, Psychological; Disease Models, Animal; Electric Stimulation; Electroencephalography; Excitatory Amino Acid Antagonists; GABA Antagonists; Genotype; Huntingtin Protein; Huntington Disease; Inhibition, Psychological; Longitudinal Studies; Male; Nerve Tissue Proteins; Neural Pathways; Neuropsychological Tests; Nuclear Proteins; Picrotoxin; Prefrontal Cortex; Psychomotor Performance; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Reflex, Startle; Synaptic Membranes; Trinucleotide Repeat Expansion | 2011 |
Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease.
Topics: Animals; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; Huntingtin Protein; Huntington Disease; Long-Term Potentiation; Mice; Mice, Transgenic; Nerve Tissue Proteins; Nuclear Proteins; Quinoxalines; Time Factors | 2007 |
Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Chick Embryo; Dibenzocycloheptenes; Dihydroxyphenylalanine; Dizocilpine Maleate; Hippocampus; Huntington Disease; Levodopa; Neurons; Parkinson Disease; Quinoxalines; Receptors, Neurotransmitter; Retina | 1990 |